Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-50,000
Closed -$61.5K 925
2025
Q2
$61.5K Hold
50,000
0.01% 489
2025
Q1
$86.8K Buy
+50,000
New +$413K 0.01% 411
2022
Q4
Sell
-130,000
Closed -$10.7M 1762
2022
Q3
$10.7M Sell
130,000
-6,100
-4% -$264K 0.71% 29
2022
Q2
$7.46M Sell
136,100
-76,000
-36% -$3.94M 0.37% 52
2022
Q1
$12.7M Buy
212,100
+27,200
+15% +$2.43M 0.53% 25
2021
Q4
$6.64M Buy
184,900
+104,900
+131% +$18M 0.18% 98
2021
Q3
$1.8M Buy
80,000
+7,100
+10% +$1.56M 0.06% 300
2021
Q2
$1.94M Buy
72,900
+56,200
+337% +$10.3M 0.06% 294
2021
Q1
$431K Sell
16,700
-8,300
-33% -$1.65M 0.02% 538
2020
Q4
$149K Sell
25,000
-5,300
-17% -$563K ﹤0.01% 1040
2020
Q3
$205K Sell
30,300
-3,500
-10% -$426K 0.01% 631
2020
Q2
$98K Buy
33,800
+18,800
+125% +$719K 0.01% 862
2020
Q1
$6K Buy
+15,000
New +$127K ﹤0.01% 1077
2019
Q2
Sell
-2,030
Closed -$16K 1288
2019
Q1
$16K Buy
+2,030
New +$64.1K ﹤0.01% 871
2016
Q4
Sell
-1,760
Closed -$67K 1152
2016
Q3
$67K Buy
+1,760
New +$227K ﹤0.01% 652
2016
Q1
Sell
-2,000
Closed -$4K 973
2015
Q4
$4K Hold
2,000
﹤0.01% 854
2015
Q3
$55K Buy
+2,000
New +$448K ﹤0.01% 690

Other funds holding NVAX

HAP Trading's NVAX Position: Q2 2022 in Review

HAP Trading sold out of Novavax (NVAX) in Q2 2022, closing a stake of 64,638 shares — an estimated $3.35M sold.

HAP Trading first reported a position in NVAX in Q2 2020 and held it in 5 quarters. The position peaked at $4.76M in Q1 2022. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • HAP Trading reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • HAP Trading sold 64,638 Novavax shares in Q2 2022, an estimated $3.35M.
  • HAP Trading first reported a position in Novavax in Q2 2020 and held it in 5 quarters.
  • HAP Trading's Novavax position peaked at $4.76M in Q1 2022.
  • 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on HAP Trading's 13F filing for Q2 2022, filed 12 Aug 2022.